Metraipolis › archive › dc_13edd1649b5e

Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report — Europe PMC PMID:29390380

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/29390380
DOI
10.1097/md.0000000000009276
License (as archived)
solo-consultazione
Archived
2026-11-07T16:02:31.970Z
SHA-256 of the archived text
c44504fdaf1cb57406d8985e2856b1c22a5f3051adb312c69d937b4e88aa0fcd
Stable URL of this page
https://metraipolis.com/documento/dc_13edd1649b5e

How to cite

Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report — Europe PMC PMID:29390380 — Europe PMC (en), https://europepmc.org/article/MED/29390380 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13edd1649b5e (Metraipolis archive dc_13edd1649b5e, sha256 c44504fdaf1cb57406d8985e2856b1c22a5f3051adb312c69d937b4e88aa0fcd)
BibTeX
@misc{dc13edd1649b5e,
  title = {Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report — Europe PMC PMID:29390380},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/29390380},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13edd1649b5e; sha256 c44504fdaf1cb57406d8985e2856b1c22a5f3051adb312c69d937b4e88aa0fcd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29390380. Agents can read the archived copy with the MCP tool read_document.